Cyclohexylalanine derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Details for Australian Patent Application No. 2005247895 (hide)

Owner Merck & Co., Inc.

Inventors Weber, Ann E.; Kirk, Brian A.; Kaelin, David E. Jr.; Duffy, Joseph L.

Agent Spruson & Ferguson

Pub. Number AU-A-2005247895

PCT Pub. Number WO2005/116029

Priority 60/572,065 18.05.04 US

Filing date 13 May 2005

Wipo publication date 8 December 2005

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

30 November 2006 PCT application entered the National Phase

  PCT publication WO2005/116029 Priority application(s): WO2005/116029

4 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005247906-Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors

2005247888-Perimetrically loading collet